Takis has been mentioned in the video reportage on “Il Fatto Quotidiano” dedicated to the three Italian companies based near Rome that are working on the development of a Covid-19 vaccine. We and our colleagues are developing  different technologies and platforms but share the same goal: fighting the coronavirus.

Our DNA-based technology  is very promising and has several advantages in terms of scalability, adaptability and costs.

Watch the full video: